Q3 2018 Holdings
Filed 2018-11-13 | 31 holdings | $11.7M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2018-11-28) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals(CPIX) | COM | 230770109 | $7.0M | 1,218,401 | 59.7% |
| Alphatec Holdings Inc(ATEC) | COM NEW | 02081G201 | $2.5M | 751,756 | 21.7% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $2.0M | 145,000 | 17.2% |
| Amarin Corp PLCA | SPONS ADR NEW | 023111206 | $24.4K | 1,500,000 | 0.2% |
| Apollo Endosurgery Inc(HQ8F) | COM | 03767D108 | $18.5K | 2,577,996 | 0.2% |
| Biospecifics Technologies(BSTC) | COM | 090931106 | $16.7K | 285,259 | 0.1% |
| Biodelivery Sciences Intl(BDSIUSD) | COM | 09060J106 | $12.1K | 4,311,103 | 0.1% |
| CTI Biopharma Corp(CTIC1USD)A | COM NEW | 12648L601 | $11.5K | 5,302,063 | 0.1% |
| Viveve Medical IncA | COM NEW | 92852W204 | $10.3K | 3,849,711 | 0.1% |
| Melinta Therapeutics Inc | COM | 58549G100 | $7.7K | 1,958,595 | 0.1% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $7.5K | 324,600 | 0.1% |
| Alimera Sciences Inc | COM | 016259103 | $6.8K | 6,987,856 | 0.1% |
| Ophthotech Corp | COM | 683745103 | $5.5K | 2,324,782 | 0.0% |
| Novelion Therapeutics Inc | COM NEW | 67001K202 | $5.1K | 1,728,887 | 0.0% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $3.7K | 225,877 | 0.0% |
| Correvio Pharma Corp | COM | 22026V105 | $3.6K | 898,157 | 0.0% |
| Opiant Pharmaceuticals Inc | COM | 683750103 | $3.3K | 185,887 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $3.2K | 551,078 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $3.1K | 138,100 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $2.9K | 656,148 | 0.0% |
| HTG Molecular Diagnostics | COM | 40434H104 | $2.7K | 535,590 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $2.4K | 226,444 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $2.0K | 378,295 | 0.0% |
| Catabasis Pharmaceuticals in | COM | 14875P107 | $1.7K | 2,166,154 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.3K | 100,000 | 0.0% |
| Neos Therapeutics Inc(NEOS) | COM | 64052L106 | $1.1K | 227,919 | 0.0% |
| Spring Bank Pharmaceuticals | COM | 849431101 | $856 | 71,050 | 0.0% |
| Cancer Genetics Inc(CGIXUSD) | COM | 13739U104 | $639 | 614,411 | 0.0% |
| Scynexis Inc | COM | 811292101 | $539 | 448,777 | 0.0% |
| Sensus Healthcare Inc(SRTS) | COM | 81728J109 | $317 | 37,858 | 0.0% |
| Dova Pharmaceuticals Inc(DOVA) | COM | 25985T102 | $145 | 6,900 | 0.0% |